BeyondSpring Inc. (BYSI) Financials

BYSI Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 14.6 million 50.6 million
March 31, 2026 18.4 million 48.8 million
Dec. 31, 2025 25.9 million 49.9 million
Sept. 30, 2025 29.5 million 49.3 million

BYSI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -3.8 million 1.0 million
March 31, 2026 -3.3 million 461000
Dec. 31, 2025 -5.7 million -77000
Sept. 30, 2025 -4.3 million 410000

BYSI Net Income

No data available :(

BYSI Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 6.5 million - -
March 31, 2026 7.9 million - 246000
Dec. 31, 2025 12.6 million - 320000
Sept. 30, 2025 12.6 million - 406000

BYSI Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 41.1 million
March 31, 2026 41.1 million
Dec. 31, 2025 40.4 million
Sept. 30, 2025 40.3 million

BYSI Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 973000 758000 -
March 31, 2026 - 1.1 million 1.2 million -
Dec. 31, 2025 249 1.5 million 1.1 million -
Sept. 30, 2025 294 1.0 million 751000 -

BYSI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 19000
Dec. 31, 2025 - 22000
Sept. 30, 2025 - 21000

BYSI

Price: $0.72

52 week price:
0.71
2.44

Earnings Per Share: -0.27 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 157900

Ebitda: -18.6 million

Market Capitalization: 41.0 million

Links: